Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Opiant Pharmaceuticals Inc (OPNT)

Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 106,641
  • Shares Outstanding, K 5,164
  • Annual Sales, $ 47,790 K
  • Annual Income, $ 3,010 K
  • 60-Month Beta 0.84
  • Price/Sales 6.54
  • Price/Cash Flow 24.75
  • Price/Book 5.20
Trade OPNT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.56
  • Most Recent Earnings $-1.93 on 11/14/22
  • Next Earnings Date 03/21/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -2.46
  • Number of Estimates 2
  • High Estimate -2.08
  • Low Estimate -2.84
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -2,336.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.00 +3.28%
on 02/02/23
21.46 -3.77%
on 02/16/23
+0.62 (+3.10%)
since 02/01/23
3-Month
19.96 +3.46%
on 01/26/23
21.46 -3.77%
on 02/16/23
+0.46 (+2.28%)
since 12/01/22
52-Week
7.34 +181.34%
on 05/13/22
29.25 -29.40%
on 03/02/22
-8.35 (-28.79%)
since 03/01/22

Most Recent Stories

More News
Deepwatch Names Mel Wesley as Chief Financial Officer

Deepwatch , the leader in advanced managed detection and response (MDR) security, announced today the appointment of Mel Wesley as Chief Financial Officer (CFO). Wesley is a seasoned finance executive...

SCOR : 13.76 (-1.43%)
FEYE : 17.27 (-3.41%)
OPNT : 20.65 (-0.58%)
OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Opiant Pharmaceuticals, Inc. (NasdaqCM: OPNT)...

OPNT : 20.65 (-0.58%)
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EQ : 0.8700 (-4.40%)
IMGO : 36.01 (+0.03%)
MTCR : 0.5814 (-1.29%)
OPNT : 20.65 (-0.58%)
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EQ : 0.8700 (-4.40%)
IMGO : 36.01 (+0.03%)
MTCR : 0.5814 (-1.29%)
OPNT : 20.65 (-0.58%)
Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook

/PRNewswire/ -- Indivior PLC (LON: INDV) will hold a Capital Markets Day today in New York City. The event will be hosted by Mark Crossley, Chief Executive...

OPNT : 20.65 (-0.58%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ELVT : 1.8700 (+0.54%)
OPNT : 20.65 (-0.58%)
BNFT : 10.50 (+0.10%)
ABMD : 381.02 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RBA, WAFD, OPNT, GRAY

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RBA : 79.72 (-1.05%)
WAFD : 34.41 (+2.38%)
OPNT : 20.65 (-0.58%)
GRAY : 5.50 (-10.80%)
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EQ : 0.8700 (-4.40%)
IMGO : 36.01 (+0.03%)
MTCR : 0.5814 (-1.29%)
OPNT : 20.65 (-0.58%)
SHAREHOLDER ALERT: Weiss Law Reminds OPNT, WAFD, MYOV, and KNBE Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

OPNT : 20.65 (-0.58%)
WAFD : 34.41 (+2.38%)
MYOV : 26.98 (-0.04%)
KNBE : 24.89 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, OPNT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ELVT : 1.8700 (+0.54%)
IMGO : 36.01 (+0.03%)
GRAY : 5.50 (-10.80%)
OPNT : 20.65 (-0.58%)

Business Summary

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.

See More

Key Turning Points

3rd Resistance Point 21.43
2nd Resistance Point 21.22
1st Resistance Point 20.93
Last Price 20.65
1st Support Level 20.43
2nd Support Level 20.22
3rd Support Level 19.93

See More

52-Week High 29.25
Fibonacci 61.8% 20.88
Last Price 20.65
Fibonacci 50% 18.30
Fibonacci 38.2% 15.71
52-Week Low 7.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar